SECTORAL ASSET MANAGEMENT INC
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
77 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 94.7% | $110,816,443 |
| Unclassified | 5.3% | $6,253,813 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | +49,347 | 79,150 | $635,574 | |
| KURA | Kura Oncology, Inc. | +17,370 | 71,480 | $581,132 | |
| GILD | Gilead Sciences, Inc. | +9,605 | 27,490 | $3,831,281 | |
| INSM | INSMED Inc | +8,486 | 19,668 | $3,216,111 | |
| BSX | Boston Scientific Corp | +7,154 | 34,780 | $2,182,445 | |
| BNTX | BioNTech SE | +4,946 | 22,164 | $1,969,936 | |
| IMTX | Immatics N.V. | +3,815 | 66,830 | $657,607 | |
| ABT | Abbott Laboratories | +2,080 | 25,578 | $2,626,093 | |
| CYTK | Cytokinetics Inc | +1,407 | 7,300 | $481,143 | |
| UNH | Unitedhealth Group Inc | +1,362 | 14,957 | $4,047,214 | |
| PRVA | Privia Health Group, Inc. | +1,136 | 27,136 | $558,187 | |
| ORIC | Oric Pharmaceuticals, Inc. | +1,020 | 23,500 | $297,745 | |
| ARGX | Argenx SE | +670 | 3,564 | $2,602,611 | |
| ISRG | Intuitive Surgical Inc | +400 | 5,250 | $2,420,197 | |
| PFE | Pfizer Inc | +350 | 27,500 | $772,200 | |
| EW | Edwards Lifesciences Corp | +88 | 17,338 | $1,388,427 | |
| MRK | Merck & Co., Inc. | +80 | 21,480 | $2,583,829 | |
| INSP | Inspire Medical Systems, Inc. | +25 | 7,225 | $372,665 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CTNM | Contineum Therapeutics, Inc. | −73,200 | 727,587 | $9,502,286 | |
| SI | Shoulder Innovations, Inc. | −62,028 | 430,407 | $6,253,813 | |
| SNDX | Syndax Pharmaceuticals Inc | −29,520 | 31,680 | $740,044 | |
| TECX | Tectonic Therapeutic, Inc. | −23,196 | 19,059 | $589,113 | |
| RAPP | Rapport Therapeutics, Inc. | −13,504 | 25,421 | $795,423 | |
| ROIV | Roivant Sciences Ltd. | −12,847 | 32,500 | $900,250 | |
| RCUS | Arcus Biosciences, Inc. | −11,875 | 45,070 | $973,512 | |
| VERA | Vera Therapeutics, Inc. | −11,285 | 25,573 | $1,028,801 | |
| OMDA | Omada Health, Inc. | −10,880 | 25,620 | $322,043 | |
| COGT | Cogent Biosciences, Inc. | −10,545 | 22,140 | $852,168 | |
| SMMT | Summit Therapeutics Inc. | −10,010 | 69,615 | $1,319,900 | |
| TRVI | Trevi Therapeutics, Inc. | −9,809 | 74,446 | $888,140 | |
| GPCR | Structure Therapeutics Inc. | −9,770 | 14,102 | $679,716 | |
| AVBP | ArriVent BioPharma, Inc. | −8,242 | 30,013 | $692,399 | |
| DXCM | Dexcom Inc | −5,469 | 23,231 | $1,458,906 | |
| ABBV | AbbVie Inc. | −4,600 | 12,200 | $2,653,378 | |
| ALHC | Alignment Healthcare, Inc. | −4,589 | 26,911 | $474,171 | |
| AMGN | Amgen Inc | −3,860 | 9,210 | $3,240,538 | |
| TARS | Tarsus Pharmaceuticals, Inc. | −3,468 | 11,272 | $790,730 | |
| BBIO | BridgeBio Pharma, Inc. | −3,070 | 8,100 | $601,506 | |
| RDNT | RadNet, Inc. | −3,001 | 7,999 | $447,064 | |
| NKTR | Nektar Therapeutics | −2,634 | 10,851 | $780,729 | |
| JNJ | Johnson & Johnson | −2,082 | 18,218 | $4,453,207 | |
| HNGE | Hinge Health, Inc. | −1,962 | 12,244 | $472,128 | |
| BMRN | Biomarin Pharmaceutical Inc | −1,430 | 9,450 | $533,830 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| IQV | Iqvia Holdings Inc. | 8,307 | $1,416,675 | |
| BMY | Bristol Myers Squibb Co | 21,150 | $1,282,747 | |
| MDT | Medtronic plc | 11,100 | $961,815 | |
| ARDX | Ardelyx, Inc. | 122,394 | $733,140 | |
| AGMB | Agomab Therapeutics NV | 43,500 | $456,315 | |
| ABVX | Abivax S.A. | 2,340 | $260,559 | |
| MEDP | Medpace Holdings, Inc. | 430 | $206,481 | |
| GH | Guardant Health, Inc. | 1,980 | $182,892 | |
| RVMD | Revolution Medicines, Inc. | 1,830 | $177,967 | |
| PALI | Palisade Bio, Inc. | 88,000 | $154,000 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| EVMN |
Evommune, Inc.
Healthcare
|
Held | 589,005 | $13,541,224 | 11.57% | |
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
Reduced | 727,587 | $9,502,286 | 8.12% | |
| SI |
Shoulder Innovations, Inc.
|
Reduced | 430,407 | $6,253,813 | 5.34% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 6,354 | $5,844,218 | 4.99% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Reduced | 18,218 | $4,453,207 | 3.80% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Added | 14,957 | $4,047,214 | 3.46% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
Added | 27,490 | $3,831,281 | 3.27% | |
| AMGN |
Amgen Inc
Healthcare
|
Reduced | 9,210 | $3,240,538 | 2.77% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 19,668 | $3,216,111 | 2.75% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
Reduced | 7,007 | $3,128,905 | 2.67% | |
| ABBV |
AbbVie Inc.
Healthcare
|
Reduced | 12,200 | $2,653,378 | 2.27% | |
| ABT |
Abbott Laboratories
Healthcare
|
Added | 25,578 | $2,626,093 | 2.24% | |
| ARGX |
Argenx SE
Healthcare
|
Added | 3,564 | $2,602,611 | 2.22% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
Added | 21,480 | $2,583,829 | 2.21% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Added | 5,250 | $2,420,197 | 2.07% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Reduced | 2,919 | $2,255,336 | 1.93% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 34,780 | $2,182,445 | 1.86% | |
| BNTX |
BioNTech SE
Healthcare
|
Added | 22,164 | $1,969,936 | 1.68% | |
| SYK |
Stryker Corp
Healthcare
|
Reduced | 5,874 | $1,930,137 | 1.65% | |
| DHR |
Danaher Corp /De/
Healthcare
|
Reduced | 9,597 | $1,819,591 | 1.55% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Reduced | 3,508 | $1,724,287 | 1.47% | |
| DXCM |
Dexcom Inc
Healthcare
|
Reduced | 23,231 | $1,458,906 | 1.25% | |
| IQV |
Iqvia Holdings Inc.
Healthcare
|
NEW | 8,307 | $1,416,675 | 1.21% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Added | 17,338 | $1,388,427 | 1.19% | |
| SMMT |
Summit Therapeutics Inc.
Healthcare
|
Reduced | 69,615 | $1,319,900 | 1.13% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
NEW | 21,150 | $1,282,747 | 1.10% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 25,573 | $1,028,801 | 0.88% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Reduced | 1,710 | $1,013,995 | 0.87% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Reduced | 45,070 | $973,512 | 0.83% | |
| MDT |
Medtronic plc
Healthcare
|
NEW | 11,100 | $961,815 | 0.82% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Reduced | 32,500 | $900,250 | 0.77% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Reduced | 74,446 | $888,140 | 0.76% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Reduced | 31,618 | $856,531 | 0.73% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 22,140 | $852,168 | 0.73% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Reduced | 25,421 | $795,423 | 0.68% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Reduced | 11,272 | $790,730 | 0.68% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Reduced | 10,851 | $780,729 | 0.67% | |
| PFE |
Pfizer Inc
Healthcare
|
Added | 27,500 | $772,200 | 0.66% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Reduced | 2,310 | $764,309 | 0.65% | |
| BOLD |
Boundless Bio, Inc.
Healthcare
|
Held | 678,574 | $746,431 | 0.64% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Reduced | 31,680 | $740,044 | 0.63% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
NEW | 122,394 | $733,140 | 0.63% | |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
Reduced | 30,013 | $692,399 | 0.59% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Reduced | 14,102 | $679,716 | 0.58% | |
| IMTX |
Immatics N.V.
Healthcare
|
Added | 66,830 | $657,607 | 0.56% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Reduced | 2,800 | $640,444 | 0.55% | |
| SPRY |
ARS Pharmaceuticals, Inc.
Healthcare
|
Added | 79,150 | $635,574 | 0.54% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Reduced | 8,100 | $601,506 | 0.51% | |
| TECX |
Tectonic Therapeutic, Inc.
Healthcare
|
Reduced | 19,059 | $589,113 | 0.50% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
Added | 71,480 | $581,132 | 0.50% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.